¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Bone type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • frontal bone
    À̸¶»À, ÀüµÎ°ñ
  • heel bone
    ¹ß²ÞÄ¡»À, Á¾°ñ
  • herring bone appearance
    û¾î»À¸ð¾ç
  • herring bone artifact
    û¾î»ÀÇã»ó, û¾î»ÀÀΰø¹°
  • hamate bone
    °¥°í¸®»À
  • hammer bone
    ¸ÁÄ¡»À
  • hip bone
    º¼±â»À, °ü°ñ
  • hyoid bone
    ¸ñ»Ô»À, ¼³°ñ
  • irregular bone
    ºÒ±ÔÄ¢»À
  • inlay bone graft
    ¼Ó³Ö±â»ÀÀ̽Ä, ºÀ¹ÚÀÌ»ÀÀ̽Ä, Àη¹À̰ñÀ̽Ä
  • innominate bone
    º¼±â»À, °ü°ñ
  • interwoven bone
    ¾ù°á»À
  • intramedullary bone graft
    ¼ÓÁú³»»ÀÀ̽Ä, °ñ¼ö³»°ñÀ̽Ä
  • lamellated bone
    ÃþÆÇ»À
  • lacrimal bone
    ´«¹°»À, ´©°ñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • bone mineral metabolism
    »À±¤¹°´ë»ç, °ñ±¤¹°Áú´ë»ç
  • brittle bone
    (¢¡osteogenesis imperfecta) ºÒ¿ÏÀü»À¹ß»ý, ºÒ¿ÏÀü°ñÇü¼ºÁõ
  • cancellous bone
    (¢¡spongy bone) °¹¼Ø»À, ÇØ¸é»À
  • capitate bone
    ¾Ë¸Ó¸®»À
  • carpal bone
    ¼Õ¸ñ»À
  • cartilage bone
    ¿¬°ñ»À
  • collar bone
    (¢¡clavicle) ºøÀå»À, ¼â°ñ
  • compact bone
    Ä¡¹Ð»À
  • cortical bone
    °ÑÁú»À
  • costal bone
    (¢¡rib) °¥ºñ»À, ´Á°ñ
  • cranial bone
    ¸Ó¸®»À, µÎ°³°ñ
  • cuboid bone
    ÀÔ¹æ»À
  • cuneiform bone
    ½û±â»À
  • ethmoid bone
    ¹úÁý»À, »ç°ñ
  • flat bone
    ³³ÀÛ»À
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • hyoid bone
    ¸ñ»Ô»À ¼³°ñ
  • hyoid bone
    ¼³°ñ
  • iliac bone <³ª> os ilium
    Àå°ñ(Àå°ñ).
  • iliac bone ³ª os ilium
    Àå°ñ(íóÍé).
  • immature compact bone
    ¹Ì¼º¼÷Ä¡¹Ð»À
  • incisive bone
    (¾Õ´Ï»À)
  • incisive bone premaxilla ; os incisivum ³ª
    ¾Õ´Ï°ñ, ÀýÄ¡°ñ(ôîöÍÍé).
  • inferior body of hyoid bone
    ¸ñ»Ô»À¾Æ·¡¸öÅë
  • inlay bone graft
    ³»Àç °ñ À̽Ä(Ò®î¤Íéì¹ãÕ), °¨ÀÔ °ñ À̽Ä(ÊîìýÍéì¹ãÕ).
  • innominate bone ³ª os coxae
    °ü°ñ.
  • innominate bone ³ª os coxae
    ¹«¸í°ñ(ÙíÙ£Íé), µÐ°ñ(ÔëÍé), °ñ¹Ý°ñ(ÍéÚïÍé), ¾ûÄ¡ »À, °ü°ñ.
  • petrosal cartilage of temporal bone
    °üÀÚ»À¹ÙÀ§¿¬°ñ
  • petrous bone
    Ãßü°ñ
  • pisiform bone
    µÎ»ó°ñ(ÔéßÒÍé).
  • pisiform bone
    Äá¾Ë»À
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • metaphyseal dysostosis dominant type
    °ñ °£´Ü¼º À̰ñÁõ ¿ì¼ºÇü(ÍéÊÏÓ®àõì¶ÍéñøéÐàõúþ).
  • mixed type of artery
    È¥ÇÕÇüµ¿¸Æ
  • mobile type diagnostic X ray apparatus
    À̵¿Çü Áø´Ü X¼± ÀåÄ¡
  • monocytic type
    ´ÜÇÙ±¸Çü(¡­û¡).
  • monocytic type
    ´ÜÇÙ±¸Çü(Ó¤ú·Ï¹û¡)
  • monocytic type
    ´ÜÇÙ±¸Çü(?Ì´).
  • muscular type of artery
    ±ÙÀ°Çüµ¿¸Æ
  • muscular type of lymphatic vessel
    ±ÙÀ°Çü¸²ÇÁ°ü
  • muscular type of vein
    ±ÙÀ°ÇüÁ¤¸Æ
  • mutation, plaque-type
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
  • on off type
    Á¡¸êÇü(ïÇØþúþ).
  • on type
    Áß½ÉÇü.
  • onion skin type
    ¾çÆÄ²®Áú¸ð¾ç
  • organic reaction type
    ±âÁú¼º ¹ÝÀÀÇü(¡­Úãëëúþ).
  • ovulatory type
    ¹è¶õÇü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Compact bone tissue
    Ä¡¹Ð»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] Ä¡¹Ð°ñÁ¶Á÷
  • Nasal bone
    ÄÚ»À
    [¿¾ ¿ë¾î] ºñ°ñ
  • Nasal bone
    ÄÚ»À [ºñ±Ù°ñ]
    [¿¾ ¿ë¾î] ºñ°ñ
  • Spongy[Cancellous] bone
    ÇØ¸é»À
    [¿¾ ¿ë¾î] ÇØ¸é°ñ
  • Yellow bone marrow
    Ȳ»ö°ñ¼ö [Ȳ»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Ȳ°ñ¼ö
  • Yellow bone marrow
    Ȳ»ö°ñ¼ö [Ȳ»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Ȳ»ö°ñ¼ö
  • (Incisive bone)
    (¾Õ´Ï»À)
    [¿¾ ¿ë¾î] ÀýÄ¡°ñ
  • Sphenoid bone
    ³ªºñ»À [Á¢Çü°ñ]
    [¿¾ ¿ë¾î] Á¢Çü°ñ
  • Hyoid bone
    ¸ñ»Ô»À [¼³°ñ]
    [¿¾ ¿ë¾î] ¼³°ñ
  • Body of hyoid bone
    ¸ñ»Ô»À¸öÅë
    [¿¾ ¿ë¾î] ¼³°ñü
  • Inferior body of hyoid bone
    ¸ñ»Ô»À¾Æ·¡¸öÅë
    [¿¾ ¿ë¾î] ¼³°ñÇÏü
  • Superior body of hyoid bone
    ¸ñ»Ô»ÀÀ§¸öÅë
    [¿¾ ¿ë¾î] ¼³°ñ»óü
  • Hip bone
    º¼±â»À [°ü°ñ]
    [¿¾ ¿ë¾î] °ü°ñ
  • Bone tissue
    »ÀÁ¶Á÷
    [¿¾ ¿ë¾î] °ñÁ¶Á÷
  • Histogenesis of bone
    »ÀÁ¶Á÷¹ß»ý
    [¿¾ ¿ë¾î] °ñ¹ß»ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
BMAP bone marrow acid phosphatase
BMB biomedical belt; bone marrow biopsy
BMF bone marrow failure
BML bone marrow lymphocytosis
BMN bone marrow necrosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
BCE Bone collagen equivalent
BC Bone conduction
BD Bone density
BFR Bone formation rate
BFR/BS Bone formation rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone hammer
    °ñ ÇØ¸Ó
  • bone hook
    °ñ±¸
  • bone inducing substance
    °ñ Çü¼º À¯µµ ÀÎÀÚ
  • bone knife
    °ñ ³ªÀÌÇÁ
  • bone ledge
    ¼±¹Ý °ñ
  • bone marrow
    °ñ¼ö
    1. »ÀÀÇ ³»°­¿¡ Â÷ ÀÖ´Â ´©¸¥ ºû ¶Ç´Â ºÓÀº ºûÀÇ ¿¬ÇÑ Á¶Á÷. 2. Ç÷±¸ »ý¼º ±â´ÉÀ» ´ã´çÇÑ´Ù. 3. ÀϹÝÀûÀ¸·Î °ñÀÇ ±¸Á¶¸¦ º¸¸é µÑ·¹´Â ´Ü´ÜÇÑ °ñÁúÀÌ ÀÖ°í °ñ°£¿¡¼­´Â Ä¡¹ÐÁú, °ñ´Ü¿¡¼­´Â ÇÇÁúÀ̶ó°í Çϴµ¥ ±× ³»ºÎ´Â °­À» ¸¸µé°í ÀÖ¾î ¼ö°­À̶ó°í ÇÑ´Ù. °ñ´Ü¿¡¼­´Â ¼ö¸¹Àº ¿¯Àº °ñÆÇÀÌ ¸Á»óÀ¸·Î ±³ÂøÇϰí ÀÖÀ¸¸ç ÇØ¸éÁúÀ̶óÇϰí ÀÌµé ¼ö°­°ú ÇØ¸éÁúÀÇ ¼Ò°­¼Ó¿¡ ÀÖ´Â °ÍÀ» °ñ¼ö¶ó ÇÑ´Ù. ÀÌ °ñ¼ö´Â º¸Åë Áö¹æÁ¶Á÷À¸·Î ä¿öÁ® ÀÖ´Ù. 4. °ñÀÇ ³»ºÎ¿¡ ÀÖ´Â ¿¬ÇÑ Á¶Á÷. °ñ¼ö°­°ú ÇØ¸éÁúÀ» ä¿ì°í ÀÖ´Â ¼¼¸Á °áÇÕ Á¶Á÷Àε¥, Àû»ö °ñ¼ö¿Í Ȳ»ö °ñ¼ö·Î ±¸º°ÇÑ´Ù. ÀüÀÚ´Â Á¶Ç÷Á¶Á÷À» Æ÷ÇÔÇÏ¿© Ç÷±¸ÀÇ »ý»ê ÀÛ¿ëÀ» Çϸç, ÈÄÀÚ´Â ÁÖ·Î Áö¹æ ¼¼Æ÷¸¦ Æ÷ÇÔÇÏ¿© ¾çºÐÀ» ÀúÀåÇÑ´Ù. ÅÂ¾Æ ¶§ºÎÅÍ Æò»ýÀ» ÅëÇÏ¿© Á¶Ç÷ ±â´ÉÀ» ¿µÀ§ÇÏ´Â Á¶Á÷À¸·Î, ÀûÇ÷±¸³ª ¹éÇ÷±¸¸¦ »ý»êÇÏ´Â Á¶Ç÷ ÀÛ¿ëÀ» ¸ÃÀº °ñ¼ö¿¡´Â Ç÷°üµµ ¸¹ÀÌ ºÐÆ÷µÇ¾î ÀÖ¾î ¾ÏÀû»öÀ» ¶ì°í, žƳª À¯À¯¾Æ¿¡ À־´Â ¸ðµç »ÀÀÇ ¼ö°­¿¡ µé¾î ÀÖ´Ù. ¿¬·ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±ä °ü»ó°ñÀÎ °ñ°£ºÎÀÇ ¼ö°­¿¡´Â Áö¹æ ¼¼Æ÷°¡ Áõ°¡ÇÏ¿© °ñ¼ö°¡ Ȳ»öÀ» ¶ì°Ô µÇ¹Ç·Î, °í·ÉÀÌ µÉ¼ö·Ï Ȳ»ö °ñ¼öÀÇ ºÐÆ÷´Â ³Ð¾îÁø´Ù. ±×·¯³ª Áö¹æÀÌ Áõ°¡ÇÑ È²»ö °ñ¼ö´Â Á¡Â÷ Á¶Ç÷ÀÛ¿ëÀÌ ¼èÅðÇÑ´Ù. Àå°ñÀÇ °ñ´Ü, ÆíÆò°ñ ¶Ç´Â ´Ü°ñ
  • bone marrow appearance
    °ñ¼ö ¼Ò°ß
  • bone marrow biopsy
    °ñ¼ö »ý°Ë¹ý
  • bone marrow cell
    °ñ¼ö ¼¼Æ÷
  • bone marrow death
    °ñ¼ö »ç
  • bone marrow embolism
    °ñ¼ö »öÀüÁõ
  • bone marrow failure
    °ñ¼ö ±â´ÉºÎÁø
  • bone marrow needle
    °ñ¼ö õÀÚ Ä§
  • bone marrow puncture
    °ñ¼ö õÀÚ
  • bone marrow suppression
    °ñ¼ö ¾ïÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
Swiss type agammaglobulinaemia Group of rare congenital disorders characterised by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an x-linked or autosomal recessive defect. About half of the patients with autosomal recessive scid are deficient in the enzyme adenosine deaminase.
(12 Dec 1998)
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
deoxyribonucleases, type II site-specific <enzyme> Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognise specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.4
(12 Dec 1998)
deoxyribonucleases, type I site-specific <enzyme> Enzyme systems containing three different subunits and requiring ATP, s-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent atpases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognise specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.3
(12 Dec 1998)
diabetes, type 1 Insulin dependent diabetes or juvenile diabetes.
(12 Dec 1998)
diabetes, type 2 Non-insulin dependent diabetes, adult-onset diabetes or insulin-resistant diabetes.
(12 Dec 1998)
disease, gaucher's type 1 A progressive genetic disease caused by a defect in an enzyme. The enzyme, called glucocerebrosidase, is needed to break down the chemical glucocerebroside. The enzyme defect in persons with Gaucher's disease (GD) leads to the accumulation of glucocerebroside in the spleen, liver, and lymph nodes. The most common early sign is enlargement of the spleen (located in the upper left abdomen). Other signs include low red blood cell counts (anaemia), a decrease in blood clotting cells (platelets), increased pigmentation of the skin, and a yellow fatty spot on the white of the eye (a pinguecula). Severe bone involvement can lead to pain and collapse of the bone of the hips, shoulders, and spine. The GD gene is on chromosome 1. The disease is a recessive trait. Both parents carry a GD gene and transmit it for their child with the disease. The parents' risk of a child with the disease is 1 in 4 with each pregnancy. This type of Gaucher's disease (noncerebral juvenile Gaucher's disease) is most common in Ashkenazi Jews (of European origin) and is the most common genetic disease among Jews in the United States.
(12 Dec 1998)
immunization, haemophilus influenzae type b See immunization, hib.
(12 Dec 1998)
influenza type a A common acute viral infection of the nasopharynx and respiratory tract which occurs in epidemic forms. A common cause is the Influenza a virus. Annual vaccination is recommended for those in high risk groups (health care workers, elderly and immunocompromised) for influenza infection.
Common symptoms include runny nose, fever, weakness, headache, body aches, muscle aches, nausea and back pain. Treatment of symptoms has been successful with amantadine or rimantadine.
(27 Sep 1997)
interferon type I <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
interferon type II <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
ocean-type fish An anadromous fish that shows no indication on its scales or other hard parts of an extended freshwater residence early in its life.
(09 Oct 1997)
Ellis type 1 glomerulonephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 1 nephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 2 glomerulonephritis An obsolete designation for glomerulonephritis which is usually not related to preceding bacterial infection; characterised by an insidious onset of the nephrotic syndrome, failure of complete remission, and eventual development of chronic renal failure. The kidneys usually show membranous glomerulonephritis.
Synonym: Ellis type 2 nephritis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á